Correction to : Neurol Ther https://doi.org/10.1007/s40120-022-00435-8

In Table 2 of this article, the data in the column headed “Route of administration, available dose” in row “CVT-301” was incorrect as it stated “Nasal inhalation” and should instead have been “Oral inhalation, 84 mg (in two 2 sequential inhalations)”.

The original article has been corrected.